Navigation Links
NKTR-102 Shows High Response Rate and Sustained Duration of Response in Women with Platinum-Resistant/Refractory Ovarian Cancer Previously Treated with Doxil®
Date:6/5/2011

CHICAGO, June 5, 2011 /PRNewswire/ -- Nektar Therapeutics (Nasdaq: NKTR) today announced positive results from a subpopulation of patients in a Phase 2 clinical study evaluating single-agent NKTR-102 in women with platinum-resistant/refractory ovarian cancer.  A total of 33 women in the study with prior Doxil® (pegylated liposomal doxorubicin or PLD) treatment were evaluable for response rate using either RECIST 1.0 criteria (response by tumor imaging) or Gynecologic Cancer InterGroup (GCIG) criteria, which is a combination of RECIST and/or ovarian cancer biomarker (CA-125) criteria.(1)  Confirmed and unconfirmed objective response rates using RECIST were 25 percent (4/16) and 29 percent (4/14) for the q14d and q21d dose schedules, respectively.  Confirmed objective response rates using RECIST were 19 percent (3/16) and 21 percent (3/14) for each dose schedule, respectively.  GCIG (confirmed and unconfirmed) response rates were 50 percent (8/16) in the once every 14 days (q14d) dose schedule and 35 percent (6/17) for the once every 21 days (q21d) dose schedule.  Confirmed objective GCIG response rates were 38 percent (6/16) and 35 percent (6/17) in the q14d and q21d dose schedules, respectively.

Median progression-free survival for all 33 patients in the subpopulation previously treated with PLD was 5.4 months and median overall survival was 13.9 months.  The median duration of confirmed response was 4.2 months in the q14d schedule and 4.4 months in the q21d schedule.

"NKTR-102 exhibits an exceptionally high response rate and long median survival compared to what would be expected in this group of heavily pre-treated women with platinum-resistant and refractory ovarian cancer," said Dr. Agustin Garcia, Associate Professor of Clinical Medicine at USC Norris Comprehensive Center.  "Women whose cancer has progressed following trea
'/>"/>

SOURCE Nektar Therapeutics
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. NKTR-102 Demonstrates Sustained Clinical Benefit in 46% of Patients with Metastatic Breast Cancer in Data Presented at 2011 American Society of Clinical Oncology Annual Meeting
2. Nektar Announces New Phase 2 Data for NKTR-102 to Be Presented at 2011 ASCO Annual Meeting
3. FDA Grants Orphan Drug Designation for Nektars Investigational Drug, NKTR-102, for Treatment of Women with Ovarian Cancer
4. NKTR-102 Demonstrates Significant Efficacy as Single-Agent in Second- or Third-Line Treatment in Metastatic Breast Cancer Patients
5. NKTR-102 Shows Encouraging Anti-Tumor Activity in Ovarian Cancer in Phase 1 and Preclinical Data Presented at the ECCO 15 and 34th ESMO Multidisciplinary Congress
6. Nektar Announces Expanded Phase 2 Clinical Development Plan For NKTR-102 (PEG-irinotecan)
7. Nektar to Webcast Presentation of Phase 1 Clinical Results for Lead Small Molecule PEG-Oncolytic Program, NKTR-102 (PEG-irinotecan)
8. Significant Anti-Tumor Activity of NKTR-102 in Patients With Refractory Solid Tumors; Interim Data Published in ASCO 2008 Proceedings
9. Additive Anti-Tumor Activity of NKTR-102 in Combination With Bevacizumab Highlighted in Positive Preclinical Data Presented at AACR Meeting
10. Nektar Commences Phase 2 Clinical Development Program for NKTR-102 (PEG-Irinotecan) in Colorectal Cancer
11. NKTR-102 (PEG-Irinotecan) Demonstrates Significant Tumor Growth Inhibition In Multiple Preclinical Tumor Models
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/22/2014)... DUBLIN , September 22, 2014 /PRNewswire/ ... ) has announced the addition of the  ... offering.       (Logo: http://photos.prnewswire.com/prnh/20130307/600769) ... used to wirelessly operate electronic gadgets such ... gaming consoles from a short line-of-sight distance. ...
(Date:9/22/2014)... DELHI , September 22, 2014 ... on   September 25   The second ... and we are excited to announce the final nominations ... will be announced on the evening of September 25 at The Taj ... were picked from applicants based on a variety of ...
(Date:9/22/2014)... -- Research and Markets has announced the ... Drugs" report to their offering. ... burden despite the presence of many cholesterol-lowering drugs in ... have been ubiquitously prescribed over the last 25 years. ... (LDLC) is the cornerstone of assessing heart risk. Irrespective ...
Breaking Medicine Technology:Global Remotes Market 2014-2018 2Global Remotes Market 2014-2018 3Recognising Impactful Healthcare Companies at VCCircle Healthcare Awards 2014 2Recognising Impactful Healthcare Companies at VCCircle Healthcare Awards 2014 3PCSK9 and Other Novel Hypercholesterolemia Drugs 2PCSK9 and Other Novel Hypercholesterolemia Drugs 3
(Date:9/23/2014)... 23, 2014) While many believe that guardian angels watch ... a new study finds that those who believe are ... protection. This study was published today in the open ... Etkin, Jelena Ivanova, Susan MacGregor, and Alalia Spektor surveyed ... in guardian angels, 68% said that this belief affects ...
(Date:9/23/2014)... On September 9th, 2014, the indoor grow community ... horticultural LED grow light that they have ever known. Kind ... and XL1000 , releasing a light that was astounding ... it has what the whole community has been waiting for: ... band spectrum (also known as "the perfect spectrum") has been ...
(Date:9/23/2014)... Dr. Mamaly Reshad, an internationally ... replacement of teeth, recently returned from speaking at ... Prosthodontics (CARDP) annual Scientific Meeting in Montreal. , ... Dental Art Institute, on Friday gave a presentation ... Prostheses” at 2:30 p.m. Friday, Sept. 19. , ...
(Date:9/23/2014)... Angeles, CA (PRWEB) September 23, 2014 ... sales funnel building software application has created a buzz ... surrounding the launch of this new software has caught ... an investigative review for her readers. , ... as site design, programming and development can be quite ...
(Date:9/23/2014)... September 23, 2014 NoteStream, an ... and exploration through the presentation of enriching content ... in the Apple® App Store. NoteStream is seeking ... and informative content to the platform. These expert ... followers and expand audience reach, and are invited ...
Breaking Medicine News(10 mins):Health News:Kind LED K5 Series XL1000 Grow Lights Sell Out in Only 2 Days 2Health News:Woodland Hills Dental Implant Center Owner, One of Ventura’s Best Cosmetic Dentists, Returns from Prestigious Speaking Engagement to Canada’s Elite Dental Professionals 2Health News:Woodland Hills Dental Implant Center Owner, One of Ventura’s Best Cosmetic Dentists, Returns from Prestigious Speaking Engagement to Canada’s Elite Dental Professionals 3Health News:Woodland Hills Dental Implant Center Owner, One of Ventura’s Best Cosmetic Dentists, Returns from Prestigious Speaking Engagement to Canada’s Elite Dental Professionals 4Health News:ClickFunnels 2.0 – Review Of Russell Brunson’s Sales Funnel Building Software Released 2Health News:Calling All Experts: New Mobile Learning App Accepting Content Contributors 2
... at UC Santa Barbara have provided a new twist ... both nature and nurture, in introducing a framework for ... how genotypes (nature) can express themselves differently as a ... current issue of the journal Social Psychological and ...
... common mental disorders in the elderly, but little is known about ... In a small study published in the ... , UCLA researchers used a unique brain scan to assess the ... a type of severe depression called major depressive disorder (MDD). ...
... good news: The body,s own immune system gets active ... the benefit of the patient. "We distinguish between two ... Umansky, immunologist at DKFZ and University Medical Center Mannheim. ... specifically attack tumor cells. On the other, however, almost ...
... , MONDAY, Nov. 7 (HealthDay News) -- The U.S. Food ... cigarette packs was derailed temporarily Monday when a federal judge ... tobacco industry,s First Amendment free-speech rights. Judge Richard ... Columbia said it was likely that the tobacco industry would ...
... painkillers are more likely to succeed in ... (Suboxone), report McLean Hospital and Harvard Medical School ... Archives of General Psychiatry. "Adjunctive Counseling ... Opioid Dependence," is the first large-scale study to ...
... has lost some ground to advances in endovascular therapy ... selected neurovascular disorders, according to a University Hospitals Case ... "Though its indications are rare, the ability to perform ... certain patients who have complex brain aneurysms or other ...
Cached Medicine News:Health News:UCSB psychology professors study gene-culture interaction 2Health News:UCSB psychology professors study gene-culture interaction 3Health News:Imaging technique IDs plaques, tangles in brains of severely depressed older adults 2Health News:Using Viagra to combat malignant melanoma 2Health News:Judge Blocks FDA Plan for Graphic Cigarette Warnings 2Health News:Judge Blocks FDA Plan for Graphic Cigarette Warnings 3Health News:Suboxone is most effective in treating painkiller addiction 2Health News:University Hospitals Case Medical Center neurosurgeons champion brain bypass in select patients 2Health News:University Hospitals Case Medical Center neurosurgeons champion brain bypass in select patients 3
... worlds first truly automatic lens-analysis system, ... lensography age. Now with new, more ... accurate resultseven with todays increasingly complex ... lens-analysis system that incorporates Wavefront technology ...
... brings new freedom and portability to ... and excellence that are the hallmark ... eyecare practitioners a simple, affordable, and ... utilizes the same proven technology of ...
Uniquely designed, the wheelchair table has dual purposes. Not only does it add a modern look to any office, it is also a heavy-duty table that will support multiple instruments, and/or easily accomm...
The Manual Table Base is elevated with an easy to reach elevating wheel for smooth operation. The table base will accept a slit lamp, a single table top, or a double tabletop for more than one instru...
Medicine Products: